January 20, 2026
Demo report #CL-2026-84521

Comprehensive Health Report

Complete Blood Panel & Metabolic Analysis with Clinical Assessment

3 Findings to review
2 Warnings
18 Normal Results
Patient Name John Mitchell
Date of Birth March 15, 1978 (47 years)
Sex Male
Ordering Provider Dr. Sarah Chen, MD (fictional)

Clinical Summary (SBAR Framework)

Structured clinical communication format for healthcare providers

S
Situation
47-year-old male presenting for routine health screening. Current labs reveal elevated cardiovascular risk markers and nutritional deficiencies requiring intervention.
B
Background
  • Family history: Father with MI at age 58
  • Lifestyle: Sedentary desk job, limited exercise
  • Previous labs (6mo ago): LDL 165, Glucose 108
  • No current medications
A
Assessment
  • Primary: Hyperlipidemia with significantly elevated LDL (189 mg/dL)
  • Secondary: Pre-diabetes (fasting glucose 118 mg/dL)
  • Tertiary: Vitamin D deficiency (18 ng/mL)
R
Recommendation
  • Review cardiovascular risk and discuss whether statin therapy is appropriate
  • Lifestyle modification: Mediterranean diet + 150min/week exercise
  • Review vitamin D supplementation options and an appropriate dose
  • Follow-up labs in 3 months
LDL Cholesterol
189
mg/dL (optimal <100)
+24 from last test
Fasting Glucose
118
mg/dL (optimal 70-99)
+10 from last test
Vitamin D
18
ng/mL (optimal 30-100)
-4 from last test
HbA1c
5.6
% (optimal <5.7%)
Stable

Identified Health Patterns

3 Patterns Detected
❤️
Cardiovascular Risk Cluster
Multiple markers indicate elevated heart disease risk
LDL 189 mg/dL ↑ Total Cholesterol 242 mg/dL LDL:HDL Ratio 3.6 Triglycerides 145 mg/dL
Clinical Connection

Elevated LDL combined with family history of cardiovascular disease places this patient in a higher risk category. The rising trend over 6 months suggests lifestyle factors are contributing. Statin therapy should be considered alongside aggressive lifestyle modification.

⚡
Metabolic Dysfunction Pattern
Early indicators of insulin resistance
Fasting Glucose 118 mg/dL ↑ HbA1c 5.6% Fasting Insulin 12 mIU/L
Clinical Connection

Elevated fasting glucose with normal HbA1c suggests early insulin resistance rather than established diabetes. This is the optimal intervention window. Dietary modification and increased physical activity can often reverse this pattern before progression to type 2 diabetes.

🌿
Nutritional Deficiency Pattern
Vitamin D insufficiency with potential systemic effects
Vitamin D 18 ng/mL ↓ B12 485 pg/mL Folate 12.5 ng/mL
Clinical Connection

Vitamin D deficiency is increasingly recognized as a contributor to both cardiovascular and metabolic dysfunction. Low vitamin D is associated with insulin resistance and may be exacerbating the metabolic pattern observed. Supplementation may provide benefits beyond bone health.

6-Month Trend Analysis

Jul 2025 - Jan 2026
LDL Cholesterol
189
+24 mg/dL (+14.5%)
LDL cholesterol trend LDL cholesterol rises across the six displayed readings, ending at 189 milligrams per decilitre.
Jul '25 Aug Sep Oct Nov Jan '26
Fasting Glucose
118
+10 mg/dL (+9.3%)
Fasting glucose trend Fasting glucose varies slightly before rising across the six displayed readings, ending at 118 milligrams per decilitre.
Jul '25 Aug Sep Oct Nov Jan '26
Vitamin D
18
-4 ng/mL (-18.2%)
Vitamin D trend Vitamin D declines across the six displayed readings, ending at 18 nanograms per millilitre.
Jul '25 Aug Sep Oct Nov Jan '26
HDL Cholesterol
52
+4 mg/dL (+8.3%)
HDL cholesterol trend HDL cholesterol improves across the six displayed readings, ending at 52 milligrams per decilitre.
Jul '25 Aug Sep Oct Nov Jan '26

Lipid Panel

Clinician review
Test Result Reference Range Change Status
Total Cholesterol 242 mg/dL <200 mg/dL ↑ +18 High
LDL Cholesterol 189 mg/dL <100 mg/dL ↑ +24 High
HDL Cholesterol 52 mg/dL >40 mg/dL ↑ +4 Normal
Triglycerides 145 mg/dL <150 mg/dL — 0 Normal
VLDL Cholesterol 29 mg/dL 5-40 mg/dL — 0 Normal
Non-HDL Cholesterol 190 mg/dL <130 mg/dL ↑ +14 High

Clinical Interpretation

Lipid profile demonstrates atherogenic dyslipidemia with significantly elevated LDL cholesterol (89 mg/dL above optimal). The rising 6-month trend indicates progressive worsening. Combined with family history of premature CAD, this profile warrants a clinician-led cardiovascular risk review. Medication choice and any LDL target should be confirmed against the patient's full history and current clinical guidance.

Metabolic Panel

Monitoring Needed
Test Result Reference Range Change Status
Fasting Glucose 118 mg/dL 70-99 mg/dL ↑ +10 Pre-diabetic
HbA1c 5.6% <5.7% — 0 Normal
Fasting Insulin 12 mIU/L 2-25 mIU/L ↑ +3 Normal
HOMA-IR 3.5 <2.5 ↑ +0.8 Elevated
Creatinine 1.0 mg/dL 0.7-1.3 mg/dL — 0 Normal
eGFR 92 mL/min >90 mL/min — 0 Normal
BUN 16 mg/dL 7-20 mg/dL — 0 Normal

Clinical Interpretation

Metabolic markers indicate early insulin resistance (HOMA-IR 3.5) with fasting glucose in pre-diabetic range. Normal HbA1c suggests recent onset of glucose dysregulation. Kidney function remains intact. This is the optimal window for lifestyle intervention to prevent progression to type 2 diabetes. Recommend glucose tolerance test if fasting glucose remains elevated at 3-month follow-up.

Vitamin & Mineral Panel

Review suggested
Test Result Reference Range Change Status
Vitamin D, 25-Hydroxy 18 ng/mL 30-100 ng/mL ↓ -4 Deficient
Vitamin B12 485 pg/mL 200-900 pg/mL — 0 Normal
Folate 12.5 ng/mL >3.0 ng/mL — 0 Normal
Iron, Serum 95 mcg/dL 60-170 mcg/dL — 0 Normal
Ferritin 125 ng/mL 30-400 ng/mL — 0 Normal
Magnesium 2.1 mg/dL 1.7-2.2 mg/dL — 0 Normal

Clinical Interpretation

Vitamin D deficiency (18 ng/mL) with declining trend requires supplementation. Low vitamin D is associated with increased cardiovascular risk, insulin resistance, and immune dysfunction - all relevant to this patient's profile. A clinician should review supplementation options, an appropriate dose, and a suitable retest interval. Further investigation may be appropriate if levels remain low.

1
Review lipid-lowering options
Discuss whether lipid-lowering medication is appropriate after reviewing the patient's complete history, risk profile, preferences, and current clinical guidance.
Clinician review: next appointment
2
Review vitamin D supplementation
Confirm whether supplementation is suitable, choose a dose for this patient, and agree on when the level should be checked again.
Clinician review: next appointment
3
Discuss nutrition and supplement use
Review dietary sources, current supplement use, contraindications, and whether an omega-3 supplement would add value for this patient.
Discuss before starting
Complete Lab Data Reference
Category Test Result Reference Status
LipidsTotal Cholesterol242 mg/dL<200High
LipidsLDL Cholesterol189 mg/dL<100High
LipidsHDL Cholesterol52 mg/dL>40Normal
LipidsTriglycerides145 mg/dL<150Normal
LipidsVLDL29 mg/dL5-40Normal
LipidsNon-HDL190 mg/dL<130High
MetabolicFasting Glucose118 mg/dL70-99High
MetabolicHbA1c5.6%<5.7%Normal
MetabolicFasting Insulin12 mIU/L2-25Normal
MetabolicHOMA-IR3.5<2.5Elevated
KidneyCreatinine1.0 mg/dL0.7-1.3Normal
KidneyeGFR92 mL/min>90Normal
KidneyBUN16 mg/dL7-20Normal
VitaminsVitamin D18 ng/mL30-100Deficient
VitaminsVitamin B12485 pg/mL200-900Normal
VitaminsFolate12.5 ng/mL>3.0Normal
MineralsIron, Serum95 mcg/dL60-170Normal
MineralsFerritin125 ng/mL30-400Normal
MineralsMagnesium2.1 mg/dL1.7-2.2Normal